About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06661174

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a...

Lead sponsor: China-Japan Friendship Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Nianrong Zhang

CONTACT

+86 188 1048 8650 znrsd@163.com

Sponsors

Lead Sponsor

China-Japan Friendship Hospital

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 18 to 65 years old;
•* BMI\>25Kg/m2 or abdominal obesity (i.e. waist circumference\>90cm for men and\>85cm for women);
•* eGFR\<30ml/min/1.73m2 or urinary microalbumin≥300mg/g, eGFR\<60ml/min/1.73m2.

Exclusion Criteria

•Patients who are taking glucocorticoids;
•* Combined with tumors; ③Combined with autoimmune diseases; ④Serum albumin\<25g/L.

Related studies

The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy

NCT06843304 · Diabetic Nephropathy, T2DM

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

NCT01802034 · Kidney Diseases, Kidney Failure, Chronic, and more

Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease

NCT06833541 · Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM), and more

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

NCT04931537 · Diabetic Nephropathy Type 2, Biomarker

Enrolling By InvitationPhase 4

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

NCT06954090 · Type 2 DM, Type 2 DM /Diabetic Nephropathy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 28, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateOct 2023

Last updatedOct 28, 2024

Condition

Bariatric Surgeries Diabetic Nephropathy

Locations shown

China-Japan Friendship Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 28, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions